Factors Associated With Off-Label Utilization of Second-Generation Antipsychotics Among Publicly Insured Adults | Zendy

Marcela HorvitzLen | Zendy; Rita Volya | Zendy; Simon Hollands | Zendy; Katya Zelevinsky | Zendy; Andrew Mulcahy | Zendy; Julie M. Donohue | Zendy; SharonLise T. Normand | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Factors Associated With Off-Label Utilization of Second-Generation Antipsychotics Among Publicly Insured Adults

Author(s) -

Marcela HorvitzLen,

Rita Volya,

Simon Hollands,

Katya Zelevinsky,

Andrew Mulcahy,

Julie M. Donohue,

SharonLise T. Normand

Publication year - 2021

Publication title -

psychiatric services

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.517

H-Index - 145

eISSN - 1557-9700

pISSN - 1075-2730

DOI - 10.1176/appi.ps.202000381

Subject(s) - medicaid , medicine , odds ratio , odds , ethnic group , confidence interval , drug utilization review , medical prescription , off label use , antipsychotic , medical expenditure panel survey , environmental health , demography , gerontology , logistic regression , psychiatry , health insurance , schizophrenia (object oriented programming) , health care , pathology , sociology , anthropology , economics , pharmacology , economic growth

Off-label utilization of second-generation antipsychotic medications may expose patients to significant risks. The authors examined the prevalence, temporal trends, and factors associated with off-label utilization of second-generation antipsychotics among publicly insured adults.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research